UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses:
General and administrative	$ 5,892,684	$ 3,120,060
Research and development	2,704,393	2,006,214
Total operating expenses	8,597,077	5,126,274
Loss from operations	(8,597,077)	(5,126,274)
Other income (expense)
Finance income	56,561	23,866
Interest (expense)	(374,712)	0
Loss on SEPA (as defined below) settlements	(127,083)	0
Total other income (expense)	(445,234)	23,866
Net loss for the period	(9,042,311)	(5,102,408)
Net loss for the period attributable to common shareholders	(9,042,311)	(5,102,408)
Foreign currency translation adjustment	(204,249)	0
Comprehensive loss for the year attributable to common shareholders	(9,246,560)	(5,102,408)
Net loss attributable to
Common shareholders of the Company	(9,042,143)	(5,102,408)
Non-controlling interests	(168)	0
Comprehensive loss attributable to
Common shareholders of the Company	(9,243,701)	(5,102,408)
Non-controlling interests	$ (2,859)	$ 0
Net loss per share attributable to common shareholders - basic	$ (0.31)	$ (0.42)
Net loss per share attributable to common shareholders - diluted	$ (0.31)	$ (0.42)
Weighted average number of common shares outstanding - basic	29,540,833	12,240,437
Weighted average number of common shares outstanding - diluted	29,540,833	12,240,437